The UMB Digital Archive is getting an upgrade! The upgrade requires a content freeze starting 1/27/25 and is expected to last two weeks. Any new user accounts or submissions made to the Archive during this time will not be transferred to the upgraded site. Contact ArchiveHelp@hshsl.umaryland.edu for questions.

Show simple item record

dc.contributor.authorAhodantin, James
dc.contributor.authorWu, Jiapeng
dc.contributor.authorTang, Lydia
dc.contributor.authorKottilil, Shyamasundaran
dc.contributor.authorSu, Lishan
dc.date.accessioned2025-01-09T18:28:03Z
dc.date.available2025-01-09T18:28:03Z
dc.date.issued2024-09-11
dc.identifier.urihttp://hdl.handle.net/10713/22942
dc.descriptionInternational HBV Meeting. September 11, 2024.en_US
dc.language.isoenen_US
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internationalen_US
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subject.meshHeplisav-Ben_US
dc.subject.meshHepatitis B Surface Antigensen_US
dc.subject.meshDNA, Viralen_US
dc.subject.meshHepatitis B, Chronicen_US
dc.subject.meshImmunityen_US
dc.subject.meshHepatitis B Vaccinesen_US
dc.subject.meshMiceen_US
dc.titleHEPLISAV-B Vaccine Elicits Effective HBs-Reactive Immune Responses to Reduce HBV DNA and Suppress HBsAg in Chronic HBV Carrier Miceen_US
dc.typePoster/Presentationen_US
refterms.dateFOA2025-01-09T18:28:04Z


Files in this item

Thumbnail
Name:
Ahodantin_HEPLISAV-B-Vaccine_2 ...
Size:
425.1Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 International
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International